Toll-like receptor 7/8 (TLR7/8) agonists, such as imiquimod (IMQ), with topical applications (e.g., 5% cream) have already been used in the clinic for treating various localized cancers (e.g., basal cell carcinoma). The gene discussed is TLR7; the disease is basal cell carcinoma.